HK2 (Hexokinase 2) catalyzes the first step of glycolysis and its upregulation in tumors is linked to enhanced glycolytic metabolism typical of cancer cells, suggesting its involvement in the Warburg effect and as a target for metabolic therapy (68). Here, HK2 is linked to cancer.